Stay updated with breaking news from Briand Ross. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new anticancer drug has been developed that is absorbed through the gut's lymphatic system, enabling the drug to outmaneuver drug resistance signaling mechanisms.
Scientists at the University of Michigan have developed an anti-cancer drug that is absorbed through the gut’s lymphatic system potentially outmaneuvering the molecular signaling pathways that lead to drug resistance.
A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways that lead to drug resistance while increasing cancer-fighting ability and reducing side effects.